Emma Reeve - Sep 3, 2021 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Director
Signature
/s/ Emma Reeve
Stock symbol
EDIT
Transactions as of
Sep 3, 2021
Transactions value $
$0
Form type
4
Date filed
9/8/2021, 04:33 PM
Previous filing
Jul 19, 2021
Next filing
Sep 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +13.7K $0.00 13.7K Sep 3, 2021 Common Stock 13.7K $68.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on September 3, 2021 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on September 3, 2022 through September 3, 2024.